skip to content

Centre for Law, Medicine and Life Sciences

Faculty of Law
 
Read more at: Professor Timo Minssen joins LML as a Research Affiliate

Professor Timo Minssen joins LML as a Research Affiliate

21 October 2022

The Centre for Law, Medicine and Life Sciences is delighted to welcome Prof. Timo Minssen (University of Copenhagen) as an Affiliate Member. The position of Affiliate covers researchers beyond the Faculty of Law who represent, participate in, or run, specific projects on behalf of LML. Prof. Minssen is Professor of Law at...


Read more at: Prof. Kathy Liddell co-authors mixed-method study on organizational decision making about Covid-19 asymptomatic testing in workplaces

Prof. Kathy Liddell co-authors mixed-method study on organizational decision making about Covid-19 asymptomatic testing in workplaces

10 October 2022

Workplace health interventions can raise complex ethical issues, for example relating to privacy, equity, and unintended consequences. The UK government and some advisory bodies issued guidance on mass asymptomatic testing for COVID-19 during waves of the pandemic, but few resources have focused specifically on the ethical...


Read more at: Prof. Kathy Liddell Represents LML at International Workshop on Antimicrobial Resistance

Prof. Kathy Liddell Represents LML at International Workshop on Antimicrobial Resistance

7 October 2022

From 5 – 6 October 2022, Prof. Kathy Liddell participated in the INAMRSS/CeBIL Copenhagen AMR Workshop: Solutions to AMR from the Social Sciences . This Workshop sought to bring together the international scholarly community – in particular those working in the social sciences – to establish a coherent evidence base to...


Read more at: Dr John Liddicoat leads LML empirical study on the repurposing of generic drugs

Dr John Liddicoat leads LML empirical study on the repurposing of generic drugs

12 September 2022

Commentators claim that drug repositioning (i.e. developing new uses for authorised drugs) significantly slows when generics are authorised and, therefore, law reform is necessary to encourage more R&D. 'Repositioning Generic Drugs: Empirical Findings and Policy Implications' empirically examines this claim by...


Read more at: Prof. Mateo Aboy co-authors patent landscape of quantum technologies

Prof. Mateo Aboy co-authors patent landscape of quantum technologies

6 July 2022

Recent technical breakthroughs underscore the potential of second generation quantum technologies, including quantum simulation, quantum sensing and metrology, quantum computation, and quantum communication. Patenting trends of such technologies are an indicator of the pace of innovation at the invention stage. Empirical...


Read more at: Jinal Dadiya featured in Diversifying the Law: Postgraduates in Profile exhibition

Jinal Dadiya featured in Diversifying the Law: Postgraduates in Profile exhibition

27 May 2022

Today, the Faculty of Law’s Equality, Diversity and Inclusivity (EDI) Committee launched its Diversifying the Law: Postgraduates in Profile exhibition. Funded by the University’s Diversity Fund, the aim of the project is to highlight and to encourage reflection on diversity and its relationship to the law—not only as...


Read more at: Dr Claire Fenton-Glynn publishes results of survey on international surrogacy arrangements

Dr Claire Fenton-Glynn publishes results of survey on international surrogacy arrangements

20 April 2022

From 18 February to 30 April 2021, Cambridge Family Law conducted an online survey to shed light on the domestic and international surrogacy arena – why it is done, how it is done, and the issues that intended parents, surrogates, and governments alike must be aware of. In doing so, the survey sought to understand the...


Read more at: LML patent research team published on European patent protection for medical uses of known products and drug repurposing

LML patent research team published on European patent protection for medical uses of known products and drug repurposing

13 April 2022

Finding new therapeutic uses for existing medicines holds significant potential, since it is often faster to develop a drug for a new use if it is already known to be safe and well tolerated by the human body. Repurposing de-risked compounds with previously known therapeutic effects is also an attractive drug development...


Read more at: Dr Liddicoat to participate in Nordic Intellectual Property Review webinar on patent repurposing for rare diseases

Dr Liddicoat to participate in Nordic Intellectual Property Review webinar on patent repurposing for rare diseases

13 April 2022

On Monday 25 April 2022, Dr John Liddicoat (LML Senior Research Associate) will participate in Patent Repositioning for rare diseases – too much, too little or just right? , a webinar organised by the Nordic Intellectual Property Review. Ensuring access to treatments for underserved populations is a key priority in both...


Read more at: American Journal of Public Health publishes article co-authored by Prof. Kathy Liddell on governing global antimicrobial resistance

American Journal of Public Health publishes article co-authored by Prof. Kathy Liddell on governing global antimicrobial resistance

23 March 2022

The American Journal of Public Health has published an article co-authored by Prof. Kathy Liddell (Director of LML) on governing global antimicrobial resistance. Antimicrobial resistance (AMR) is among the most urgent global health challenges of our time. AMR can develop with each use of an antimicrobial, regardless of the...